| In 2005,
the US Food and Drug Administration (FDA) approved PEGASYS for
the treatment of chronic hepatitis B. Already the most prescribed
hepatitis C medication in the United States, PEGASYS is the
first and only pegylated interferon
approved for the treatment of chronic hepatitis B, including
both main types of the virus.
PEGASYS
helps in two important ways:
- PEGASYS
slows replication of the hepatitis B virus.
- PEGASYS boosts the body's immune system.
Pegasys
Product Information
(Pegasys for treatment of Hepatitis B starts on page 25 of
PDF)
HBV
Pegasys Roche Web Page
|
Articles on Pegasys (peginterferon alfa-2a)
for Treatment of Hepatitis B
